Cancer statistics, 2018 - PubMed (original) (raw)
doi: 10.3322/caac.21442. Epub 2018 Jan 4.
Affiliations
- PMID: 29313949
- DOI: 10.3322/caac.21442
Free article
Cancer statistics, 2018
Rebecca L Siegel et al. CA Cancer J Clin. 2018 Jan.
Free article
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2015, were collected by the National Center for Health Statistics. In 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2005-2014) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2006-2015) declined by about 1.5% annually in both men and women. The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak. Of the 10 leading causes of death, only cancer declined from 2014 to 2015. In 2015, the cancer death rate was 14% higher in non-Hispanic blacks (NHBs) than non-Hispanic whites (NHWs) overall (death rate ratio [DRR], 1.14; 95% confidence interval [95% CI], 1.13-1.15), but the racial disparity was much larger for individuals aged <65 years (DRR, 1.31; 95% CI, 1.29-1.32) compared with those aged ≥65 years (DRR, 1.07; 95% CI, 1.06-1.09) and varied substantially by state. For example, the cancer death rate was lower in NHBs than NHWs in Massachusetts for all ages and in New York for individuals aged ≥65 years, whereas for those aged <65 years, it was 3 times higher in NHBs in the District of Columbia (DRR, 2.89; 95% CI, 2.16-3.91) and about 50% higher in Wisconsin (DRR, 1.78; 95% CI, 1.56-2.02), Kansas (DRR, 1.51; 95% CI, 1.25-1.81), Louisiana (DRR, 1.49; 95% CI, 1.38-1.60), Illinois (DRR, 1.48; 95% CI, 1.39-1.57), and California (DRR, 1.45; 95% CI, 1.38-1.54). Larger racial inequalities in young and middle-aged adults probably partly reflect less access to high-quality health care. CA Cancer J Clin 2018;68:7-30. © 2018 American Cancer Society.
Keywords: cancer cases; cancer statistics; death rates; incidence; mortality.
© 2018 American Cancer Society.
Comment in
- Updated statistics of lung and bronchus cancer in United States (2018).
Boloker G, Wang C, Zhang J. Boloker G, et al. J Thorac Dis. 2018 Mar;10(3):1158-1161. doi: 10.21037/jtd.2018.03.15. J Thorac Dis. 2018. PMID: 29708136 Free PMC article. No abstract available.
Similar articles
- Cancer Statistics, 2017.
Siegel RL, Miller KD, Jemal A. Siegel RL, et al. CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5. CA Cancer J Clin. 2017. PMID: 28055103 - Colorectal cancer statistics, 2017.
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Siegel RL, et al. CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1. CA Cancer J Clin. 2017. PMID: 28248415 - Cancer statistics, 2019.
Siegel RL, Miller KD, Jemal A. Siegel RL, et al. CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8. CA Cancer J Clin. 2019. PMID: 30620402 - Cancer statistics, 2012.
Siegel R, Naishadham D, Jemal A. Siegel R, et al. CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22237781 - Cancer statistics, 2020.
Siegel RL, Miller KD, Jemal A. Siegel RL, et al. CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8. CA Cancer J Clin. 2020. PMID: 31912902
Cited by
- Melatonin Mitigates Cisplatin-Induced Submandibular Gland Damage by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Fibrosis.
Badawy AM, Ibrahim M, Taha M, Helal AI, Elmetwally AA, El-Shenbaby I, Abubakr S, Hussin E, Sakr NH, Baokbah TAS, Farage AE. Badawy AM, et al. Cureus. 2024 Sep 3;16(9):e68515. doi: 10.7759/cureus.68515. eCollection 2024 Sep. Cureus. 2024. PMID: 39364499 Free PMC article. - Male and female disparities in breast cancer epidemiology: A comparative cross-sectional analysis of a Brazilian cohort (2017-2021).
Antonini M, Mattar A, Pannain GD, Buttenbender SF, Pinheiro DJPDC, Teixeira MD, Amorim AG, Ferraro O, Lopes RGC, Gebrim LH. Antonini M, et al. Heliyon. 2024 Sep 20;10(18):e38183. doi: 10.1016/j.heliyon.2024.e38183. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39364238 Free PMC article. - Temporal Trends in Racial and Gender Disparities of Early Onset Colorectal Cancer in the United States: An Analysis of the CDC WONDER Database.
Nawras Y, Merza N, Beier K, Dakroub A, Al-Obaidi H, Al-Obaidi AD, Amatul-Raheem H, Bahbah E, Varughese T, Hosny J, Hassan M, Kobeissy A. Nawras Y, et al. J Gastrointest Cancer. 2024 Dec;55(4):1511-1519. doi: 10.1007/s12029-024-01096-6. Epub 2024 Oct 1. J Gastrointest Cancer. 2024. PMID: 39352432 Review. - Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response.
Hashemi M, Khosroshahi EM, Daneii P, Hassanpoor A, Eslami M, Koohpar ZK, Asadi S, Zabihi A, Jamali B, Ghorbani A, Nabavi N, Memarkashani MR, Salimimoghadam S, Taheriazam A, Tan SC, Entezari M, Farahani N, Hushmandi K. Hashemi M, et al. Noncoding RNA Res. 2024 Sep 11;10:98-115. doi: 10.1016/j.ncrna.2024.09.006. eCollection 2025 Feb. Noncoding RNA Res. 2024. PMID: 39351450 Free PMC article. Review. - Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies.
Thakur N, Singh P, Bagri A, Srivastava S, Dwivedi V, Singh A, Jaiswal SK, Dholpuria S. Thakur N, et al. Explor Target Antitumor Ther. 2024;5(5):1110-1134. doi: 10.37349/etat.2024.00266. Epub 2024 Aug 29. Explor Target Antitumor Ther. 2024. PMID: 39351434 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous